Back

CDK4/6 inhibitor ribociclib induces cardiotoxicity through impaired E2F1-regulated spliceosome assembly

20 June 2025 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms of cancer treatment-related cardiovascular toxicity Research and New Technology CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Ms Eva Pet

University Medical Centre Groningen, Groningen (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Targeted cardiac inactivation of Guanylate binding protein 5 (GBP5) protects from cardiotoxicity after radiation
Doctor M. Heckmann (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Cell painting based high-content phenotypic screening to elucidate kinase signaling pathways in ibrutinib-mediated atrial fibrillation
Doctor M. Fleming (Jacksonville, US)
Abstract Slides Video
Presentation thumbnail
Mismatch between pre-clinical cardio-oncology and clinical oncology research
Mr M. Stabile (Genoa, IT)
Abstract Slides Video
Presentation thumbnail
Early myocardial metabolic signatures of anthracycline-induced cardiotoxicity
Mr C. Galan (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms of cancer treatment-related cardiovascular toxicity

The Event

Event poster

ESC Cardio-Oncology 2025

20 June - 21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources